Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.73
$0.06(7.89%)
At close: 4:00 PM EDT
$0.73
$0.06(7.89%)
Day’s Range― - ―
52-Week Range$0.55 - $2.69
Previous CloseN/A
Volume298.38K
Average Volume (3M)1.04M
Market Cap
$78.08M
Enterprise Value$250.71
Total Cash (Recent Filing)$206.10M
Total Debt (Recent Filing)$367.10M
Price to Earnings (P/E)―
Beta1.95
Next Earnings
Nov 10, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding130,140,760
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio5.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1.23Price Target Upside67.81% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-0.17
Revenue Forecast (FY)$286.15M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue BaseThe installed base supports repeat consumables revenue after device placement, creating a more durable model than one-time equipment sales. Continued system growth and high recurring mix can improve revenue visibility and customer retention over time.
Margin ExpansionMaterial gross-margin expansion and higher adjusted EBITDA indicate operational efficiencies, lower equipment costs and favorable mix are improving economics. If sustained, these gains can provide operating leverage and strengthen the platform's profitability potential.
Positive Cash GenerationPositive operating and free cash flow show that the installed platform can convert business activity into cash even before GAAP profitability is achieved. This supports investment in products and commercialization, although consistency will remain important.
Bears Say
Declining Revenue OutlookLower revenue guidance and recent sales contraction indicate that the business has not yet restored durable growth. Persistent top-line weakness could limit scale benefits, reduce reinvestment capacity and make the margin improvement harder to sustain.
High Leverage And Maturity RiskThe highly leveraged capital structure leaves limited balance-sheet cushion if operating performance weakens. The sizable convertible maturity could absorb cash that might otherwise fund growth, increasing financial flexibility and execution risks.
Weak Provider UtilizationDeclines in both equipment placements and consumables suggest pressure across customer acquisition and treatment utilization, not only a single product line. Lower provider activity can weaken the installed-base flywheel and delay recurring revenue recovery.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.55 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $78.08M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Nov 10, 2026 which is in 83 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on Aug 06, 2026. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.025 by $0.005.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.06.
How many shares outstanding does Beauty Health have?
Beauty Health has 130,140,760 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.025. Following the earnings report the stock price went down -13.82%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.23 (67.81% Upside)
$1.23 (67.81% Upside)
Blogger Sentiment
Neutral
SKIN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 319.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.14%
Trailing 12-Months
Company Description
Beauty Health
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: strong margin improvement, adjusted EBITDA upside and tangible strategic progress (rental program, product pipeline, installed‑base monetization) are positive. However, meaningful top‑line weakness — driven by an 18.4% decline in equipment revenue, continued consumables softness, regional softness in EMEA, and near‑term balance sheet and Nasdaq listing risks — tempers the outlook. Management is focused on execution and long‑term investments, but near‑term revenue and capital markets pressures balance the positives.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$1.23
▲(67.81% Upside)
Technical Analysis
Ownership Overview
7.84% Insiders
11.07% Mutual Funds
22.11% Other Institutional Investors
55.89% Public Companies and
Individual Investors